Ushira Kapilani Withanaarachchi

Dr. Ushira Kapilani Withanaarachchi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YMYatin Mehta
Yatin Mehta
RPRAJIB PAUL
RAJIB PAUL
RRRaihan Rabbani
Raihan Rabbani
SASubhash Prasad Acharya
Subhash Prasad Acharya
UWUshira Kapilani Withanaarachchi
Ushira Kapilani Withanaarachchi
Sepsis is a life-threatening condition that causes a global health burden associated with high mortality and morbidity. Often life-threatening, sepsis can be caused by bacteria, viruses, parasites or fungi. Sepsis management primarily focuses on source control and early broad-spectrum antibiotics, plus organ function support. Comprehensive changes in the way we manage sepsis patients include early identification, infective focus identification and immediate treatment with antimicrobial therapy, appropriate supportive care and hemodynamic optimization. Despite all efforts of clinical and experimental research over thirty years, the capacity to positively influence the outcome of the disease remains limited. This can be due to limited studies available on sepsis in developing countries, especially in Southeast Asia. This review summarizes the progress made in the diagnosis and time associated with sepsis, colistin resistance and chloramphenicol boon, antibiotic abuse, resource constraints and association of sepsis with COVID-19 in Southeast Asia. A personalized approach and innovative therapeutic alternatives such as CytoSorb® are highlighted as potential options for the treatment of patients with sepsis in Southeast Asia.

22 May 2020 in Perfusion
Verified
Journal Article
Closed access
PDF file
THTolusha Harischandra
Tolusha Harischandra
UWUshira Kapilani Withanaarachchi
Ushira Kapilani Withanaarachchi
BPBhagya Piyasiri
Bhagya Piyasiri
HWHesaru Wickramasuriya
Hesaru Wickramasuriya
GPGihan Piyasiri
Gihan Piyasiri
RFRichard Firmin
Richard Firmin
While there is evidence to support the use of extracorporeal membrane oxygenation in acute respiratory distress syndrome due to a variety of causes, its use in chlorine gas–induced acute respiratory distress syndrome has not been described in the English medical literature. We present a young girl who had severe acute respiratory distress syndrome following exposure to chlorine gas during the disinfection process at a swimming pool. She failed conventional management and underwent venovenous extracorporeal membrane oxygenation. Despite multiple infections and a pneumothorax, she eventually recovered. Chlorine gas was the first agent of chemical warfare which caused a massive death toll during the First World War. Even today, the chemical is produced in large quantities and the threat of a large-scale leak is ever-present from industrial accidents or terrorist attacks. The criteria to assess and manage chlorine gas–induced acute respiratory distress syndrome are likely to be the same as for other causes of acute respiratory distress syndrome and extracorporeal membrane oxygenation can be used successfully.

30 December 2021 in Journal of the University of Ruhuna
Verified
Journal Article
Open access
PDF file
PKPrathibha Janani Kariyawasam
Prathibha Janani Kariyawasam
UWUshira Kapilani Withanaarachchi
Ushira Kapilani Withanaarachchi
THTolusha Harischandra
Tolusha Harischandra
MJMilinda Jayawardana
Milinda Jayawardana
LCLala Chandilini
Lala Chandilini
Extra Corporeal Membrane Oxygenation (ECMO) is used as a rescue therapy in cardiac and respiratory failure until the reversible condition settles. It provides extracorporeal circulation for gas and heat exchange before entering the patient. While the use of ECMO has been advancing as a promising life-saving modality since 1953, our country still lags behind, having only one ECMO centre for the whole country. The need to improve ECMO is emphasized by the fact that candidates who had grim prognosis being survived by using ECMO. This is the story of a term baby weighing 3770 g who had severe meconium aspiration at birth, requiring intubation within first hour for severe respiratory distress. Irrespective of High Frequency Oscillatory Ventilation and four inotropes baby had refractory desaturation, hypotension and rising oxygen index with a cardiac arrest needing both cardiac and respiratory support for survival. Baby was commenced on Veno-Arterial ECMO monitoring vitals, cardiac status respiration, coagulation, cerebral status for haemorrhage, electrolytes, renal and liver status while treating for sepsis. Our baby fully recovered without complications, while precious smile on the face of the baby highlights an important point, Hi-Tech measures in proper manner do account for their survival and normal development. Progress beyond ‘Ambulatory-ECMO’ shows how advanced technology can be well utilized for patients’ benefits. It is important to expand and improve ECMO facilities in Sri Lanka aiming at a better survival of our patients.

4 September 2021 in Sri Lanka Journal of Child Health
Verified
Journal Article
Open access
PDF file
VSV. P. Sinhabahu
V. P. Sinhabahu
UWUshira Kapilani Withanaarachchi
Ushira Kapilani Withanaarachchi
MLM. N. Lucas
M. N. Lucas
KKK. M. T. Kumara
K. M. T. Kumara
KPK. M. Parakrama Parakrama
K. M. Parakrama Parakrama

5 March 2020 in Sri Lanka Journal of Child Health
Verified
Journal Article
Open access
PDF file
NVNimantha Dhananjaya Vithanage
Nimantha Dhananjaya Vithanage
UWUshira Kapilani Withanaarachchi
Ushira Kapilani Withanaarachchi
IKImalke Kankananarachchi
Imalke Kankananarachchi
MJMilinda Jayawardena
Milinda Jayawardena
Sri Lanka Journal of Child Health, 2020; 49(1): 90-93